Occult hepatitis B virus infection in Chinese cryptogenic intrahepatic cholangiocarcinoma patient population

Journal of Clinical Gastroenterology

Volumn 48, Issue 10, 2014, Pages 878-882

  Li, Yu Qiong ^a   Wang, Hui ^a   Li, Da Peng ^b   Hu, Jing Yi ^c   Wang, Hao ^a   Zhou, Dong Xun ^a   Li, Qiao Mei ^a   Jiang, Xiao Lan ^a   Zhou, Hua Bang ^a   Hu, He Ping ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b BENGBU MEDICAL COLLEGE   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Carcinogenesis; Intrahepatic cholangiocarcinoma; Occult hepatitis B virus

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; VIRUS DNA; BIOLOGICAL MARKER; HEPATITIS B ANTIBODY;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER PATIENT; CASE CONTROL STUDY; CAVERNOUS HEMANGIOMA; CHINESE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LIVER; MAJOR CLINICAL STUDY; MALE; OCCULT HEPATITIS B VIRUS INFECTION; PREVALENCE; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; ASIAN CONTINENTAL ANCESTRY GROUP; BILE DUCT NEOPLASMS; BLOOD; CHI SQUARE DISTRIBUTION; CHINA; CHOLANGIOCARCINOMA; ETHNOLOGY; GENETICS; IMMUNOLOGY; INTRAHEPATIC BILE DUCT; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK; RISK FACTOR; STATISTICAL MODEL; VIROLOGY; YOUNG ADULT;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; CHINA; CHOLANGIOCARCINOMA; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PREVALENCE; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84916200269     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/mcg.0000000000000058     Document Type: Article

References (26)

1. EASL-EORTC clinical practice guidelines: Management of hepatocellular carcinoma. J Hepatol. 2012;56: 908-943.
2. Fwu CW, Chien YC, You SL, et al. Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: A cohort study of parous women in Taiwan. Hepatology. 2011;53: 1217-1225.
3. Lee CH, Chang CJ, Lin YJ, et al. Viral hepatitis-associated intrahepatic cholangiocarcinoma shares common disease processes with hepatocellular carcinoma. Br J Cancer. 2009;100: 1765-1770.
4. Zhou H, Wang H, Zhou D, et al. Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis. Eur J Cancer. 2010;46: 1056-1061.
5. Hughes NR, Pairojkul C, Royce SG, et al. Liver flukeassociated and sporadic cholangiocarcinoma: An immunohistochemical study of bile duct, peribiliary gland and tumour cell phenotypes. J Clin Pathol. 2006;59: 1073-1078.
6. Chalasani N, Baluyut A, Ismail A, et al. Cholangiocarcinoma in patients with primary sclerosing cholangitis: A multicenter case-control study. Hepatology. 2000;31: 7-11.
7. Shaib YH, El-Serag HB, Davila JA, et al. Risk factors of intrahepatic cholangiocarcinoma in the United States: A casecontrol study. Gastroenterology. 2005;128: 620-626.
8. Yuen MF, Wong DK, Fung J, et al. HBsAg Seroclearance in chronic hepatitis B in Asian patients: Replicative level and risk of hepatocellular carcinoma. Gastroenterology. 2008;135: 1192-1199.
9. Yuen MF, Wong DK, Sablon E, et al. HBsAg seroclearance in chronic hepatitis B in the Chinese: Virological, histological, and clinical aspects. Hepatology. 2004;39: 1694-1701.
10. Raimondo G, Pollicino T, Cacciola I, et al. Occult hepatitis B virus infection. J Hepatol. 2007;46: 160-170.
11. Raimondo G, Pollicino T, Romano L, et al. A 2010 update on occult hepatitis B infection. Pathol Biol (Paris). 2010;58: 254-257.
12. Hollinger FB, Sood G. Occult hepatitis B virus infection: A covert operation. J Viral Hepat. 2010;17: 1-15.
13. Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect Dis. 2002;2: 479-486.
14. Raimondo G, Navarra G, Mondello S, et al. Occult hepatitis B virus in liver tissue of individuals without hepatic disease. J Hepatol. 2008;48: 743-746.
15. Cacciola I, Pollicino T, Squadrito G, et al. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med. 1999;341: 22-26.
16. Chemin I, Trepo C. Clinical impact of occult HBV infections. J Clin Virol. 2005;34(suppl 1): S15-S21.
17. Hu KQ. Occult hepatitis B virus infection and its clinical implications. J Viral Hepat. 2002;9: 243-257.
18. Mulrooney-Cousins PM, Michalak TI. Persistent occult hepatitis B virus infection: Experimental findings and clinical implications. World J Gastroenterol. 2007;13: 5682-5686.
19. Brechot C. Pathogenesis of hepatitis B virus-related hepatocellular carcinoma: Old and new paradigms. Gastroenterology. 2004;127: S56-S61.
20. Chemin I, Zoulim F. Hepatitis B virus induced hepatocellular carcinoma. Cancer Lett. 2009;286: 52-59.
21. Raimondo G, Allain JP, Brunetto MR, et al. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol. 2008;49: 652-657.
22. Nirei K, Kaneko M, Moriyama M, et al. The clinical features of chronic hepatitis C are not affected by the coexistence of hepatitis B virus DNA in patients negative for hepatitis B surface antigen. Intervirology. 2000;43: 95-101.
23. Ahn SH, Park YN, Park JY, et al. Long-term clinical and histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance. J Hepatol. 2005;42: 188-194.
24. Shiota G, Oyama K, Udagawa A, et al. Occult hepatitis B virus infection in HBs antigen-negative hepatocellular carcinoma in a Japanese population: Involvement of HBx and p53. J Med Virol. 2000;62: 151-158.
25. De Mitri MS, Cassini R, Bernardi M. Hepatitis B virus-related hepatocarcinogenesis: Molecular oncogenic potential of clear or occult infections. Eur J Cancer. 2010;46: 2178-2186.
26. Squadrito G, Pollicino T, Cacciola I, et al. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients. Cancer. 2006;106: 1326-1330.